Our results suggested a novel route by which DEPDC1B regulates Rac1 activation and modulates ERK1/2 activities, and offer an explanation for the mechanism by which DEPDC1b contributes to anchorage-independent growth in oral cancer cells. The gene discussed is MAPK3; the disease is lip and oral cavity carcinoma.